Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005829 | cytosol | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HFZ8
Term | Name | Level | Count |
---|---|---|---|
GO:0006470 | protein dephosphorylation | 5 | 12 |
GO:0006793 | phosphorus metabolic process | 3 | 12 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016311 | dephosphorylation | 5 | 12 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0036211 | protein modification process | 4 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
GO:0007165 | signal transduction | 2 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 12 |
GO:0008138 | protein tyrosine/serine/threonine phosphatase activity | 4 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 12 |
GO:0016791 | phosphatase activity | 5 | 12 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 12 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 12 |
GO:0004725 | protein tyrosine phosphatase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 119 | 121 | PF00675 | 0.573 |
CLV_NRD_NRD_1 | 152 | 154 | PF00675 | 0.491 |
CLV_NRD_NRD_1 | 289 | 291 | PF00675 | 0.393 |
CLV_NRD_NRD_1 | 337 | 339 | PF00675 | 0.724 |
CLV_NRD_NRD_1 | 352 | 354 | PF00675 | 0.372 |
CLV_NRD_NRD_1 | 73 | 75 | PF00675 | 0.617 |
CLV_PCSK_KEX2_1 | 337 | 339 | PF00082 | 0.575 |
CLV_PCSK_SKI1_1 | 146 | 150 | PF00082 | 0.658 |
CLV_PCSK_SKI1_1 | 44 | 48 | PF00082 | 0.444 |
DEG_SPOP_SBC_1 | 156 | 160 | PF00917 | 0.507 |
DEG_SPOP_SBC_1 | 64 | 68 | PF00917 | 0.496 |
DOC_CKS1_1 | 61 | 66 | PF01111 | 0.502 |
DOC_CYCLIN_RxL_1 | 141 | 152 | PF00134 | 0.500 |
DOC_CYCLIN_RxL_1 | 26 | 36 | PF00134 | 0.495 |
DOC_CYCLIN_RxL_1 | 287 | 297 | PF00134 | 0.360 |
DOC_MAPK_gen_1 | 227 | 237 | PF00069 | 0.189 |
DOC_MAPK_MEF2A_6 | 307 | 316 | PF00069 | 0.200 |
DOC_PP1_RVXF_1 | 27 | 34 | PF00149 | 0.490 |
DOC_PP4_FxxP_1 | 61 | 64 | PF00568 | 0.505 |
DOC_USP7_MATH_1 | 156 | 160 | PF00917 | 0.797 |
DOC_USP7_MATH_1 | 165 | 169 | PF00917 | 0.733 |
DOC_USP7_MATH_1 | 174 | 178 | PF00917 | 0.629 |
DOC_USP7_MATH_1 | 341 | 345 | PF00917 | 0.515 |
DOC_USP7_MATH_1 | 64 | 68 | PF00917 | 0.580 |
DOC_WW_Pin1_4 | 152 | 157 | PF00397 | 0.603 |
DOC_WW_Pin1_4 | 308 | 313 | PF00397 | 0.266 |
DOC_WW_Pin1_4 | 53 | 58 | PF00397 | 0.773 |
DOC_WW_Pin1_4 | 60 | 65 | PF00397 | 0.730 |
LIG_14-3-3_CanoR_1 | 212 | 222 | PF00244 | 0.296 |
LIG_14-3-3_CanoR_1 | 293 | 303 | PF00244 | 0.335 |
LIG_14-3-3_CanoR_1 | 32 | 38 | PF00244 | 0.444 |
LIG_BH_BH3_1 | 119 | 135 | PF00452 | 0.271 |
LIG_BRCT_BRCA1_1 | 177 | 181 | PF00533 | 0.411 |
LIG_BRCT_BRCA1_1 | 247 | 251 | PF00533 | 0.200 |
LIG_BRCT_BRCA1_1 | 341 | 345 | PF00533 | 0.372 |
LIG_EH1_1 | 186 | 194 | PF00400 | 0.267 |
LIG_EVH1_2 | 57 | 61 | PF00568 | 0.499 |
LIG_FHA_1 | 138 | 144 | PF00498 | 0.577 |
LIG_GBD_Chelix_1 | 122 | 130 | PF00786 | 0.257 |
LIG_LIR_Apic_2 | 59 | 64 | PF02991 | 0.506 |
LIG_LIR_Gen_1 | 231 | 239 | PF02991 | 0.269 |
LIG_LIR_Gen_1 | 254 | 263 | PF02991 | 0.303 |
LIG_LIR_Nem_3 | 231 | 237 | PF02991 | 0.268 |
LIG_LIR_Nem_3 | 25 | 31 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 254 | 258 | PF02991 | 0.303 |
LIG_LIR_Nem_3 | 35 | 40 | PF02991 | 0.357 |
LIG_Pex14_1 | 197 | 201 | PF04695 | 0.331 |
LIG_Pex14_2 | 228 | 232 | PF04695 | 0.281 |
LIG_Pex14_2 | 251 | 255 | PF04695 | 0.325 |
LIG_REV1ctd_RIR_1 | 25 | 33 | PF16727 | 0.495 |
LIG_RPA_C_Fungi | 115 | 127 | PF08784 | 0.494 |
LIG_SH2_CRK | 234 | 238 | PF00017 | 0.280 |
LIG_SH2_STAT3 | 323 | 326 | PF00017 | 0.189 |
LIG_SH2_STAT5 | 287 | 290 | PF00017 | 0.281 |
LIG_SH3_3 | 2 | 8 | PF00018 | 0.483 |
LIG_SH3_3 | 223 | 229 | PF00018 | 0.266 |
LIG_WW_3 | 7 | 11 | PF00397 | 0.473 |
MOD_CK1_1 | 158 | 164 | PF00069 | 0.679 |
MOD_CK1_1 | 56 | 62 | PF00069 | 0.701 |
MOD_CK1_1 | 66 | 72 | PF00069 | 0.680 |
MOD_CK2_1 | 165 | 171 | PF00069 | 0.593 |
MOD_GlcNHglycan | 13 | 16 | PF01048 | 0.536 |
MOD_GlcNHglycan | 161 | 164 | PF01048 | 0.648 |
MOD_GlcNHglycan | 167 | 170 | PF01048 | 0.555 |
MOD_GlcNHglycan | 237 | 240 | PF01048 | 0.411 |
MOD_GlcNHglycan | 284 | 287 | PF01048 | 0.479 |
MOD_GlcNHglycan | 296 | 299 | PF01048 | 0.350 |
MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.691 |
MOD_GSK3_1 | 152 | 159 | PF00069 | 0.752 |
MOD_GSK3_1 | 275 | 282 | PF00069 | 0.300 |
MOD_GSK3_1 | 339 | 346 | PF00069 | 0.383 |
MOD_GSK3_1 | 49 | 56 | PF00069 | 0.658 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.684 |
MOD_GSK3_1 | 76 | 83 | PF00069 | 0.745 |
MOD_NEK2_1 | 104 | 109 | PF00069 | 0.450 |
MOD_NEK2_1 | 196 | 201 | PF00069 | 0.325 |
MOD_NEK2_1 | 292 | 297 | PF00069 | 0.283 |
MOD_NEK2_1 | 33 | 38 | PF00069 | 0.510 |
MOD_NEK2_2 | 182 | 187 | PF00069 | 0.337 |
MOD_PIKK_1 | 221 | 227 | PF00454 | 0.240 |
MOD_PIKK_1 | 322 | 328 | PF00454 | 0.189 |
MOD_PKA_1 | 44 | 50 | PF00069 | 0.458 |
MOD_PKA_2 | 11 | 17 | PF00069 | 0.693 |
MOD_PKA_2 | 292 | 298 | PF00069 | 0.215 |
MOD_Plk_4 | 279 | 285 | PF00069 | 0.358 |
MOD_ProDKin_1 | 152 | 158 | PF00069 | 0.605 |
MOD_ProDKin_1 | 308 | 314 | PF00069 | 0.266 |
MOD_ProDKin_1 | 53 | 59 | PF00069 | 0.774 |
MOD_ProDKin_1 | 60 | 66 | PF00069 | 0.728 |
MOD_SUMO_rev_2 | 67 | 77 | PF00179 | 0.507 |
TRG_ENDOCYTIC_2 | 234 | 237 | PF00928 | 0.272 |
TRG_ENDOCYTIC_2 | 37 | 40 | PF00928 | 0.283 |
TRG_Pf-PMV_PEXEL_1 | 318 | 322 | PF00026 | 0.189 |
TRG_Pf-PMV_PEXEL_1 | 338 | 343 | PF00026 | 0.504 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDK0 | Leptomonas seymouri | 45% | 100% |
A0A0S4J521 | Bodo saltans | 39% | 100% |
A0A1X0NRN9 | Trypanosomatidae | 49% | 100% |
A0A3S7X0Z1 | Leishmania donovani | 73% | 100% |
A0A422N807 | Trypanosoma rangeli | 37% | 100% |
A4I317 | Leishmania infantum | 73% | 100% |
C9ZJI6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
E9ACT8 | Leishmania major | 72% | 99% |
E9AZC7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 70% | 100% |
V5BIV4 | Trypanosoma cruzi | 39% | 100% |